Analysis

COVID-19 A data perspective

COVID-19: A data perspective: Explore key economic trends and social challenges that arise as the COVID-19 situation evolves.

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Year of publication

1 facets displayed. 0 facets selected.

Author(s)

2 facets displayed. 1 facets selected.
Sort Help
entries

Results

All (2)

All (2) ((2 results))

  • Articles and reports: 88F0006X2003013
    Description:

    This paper used data from the 2001 Biotechnology Use and Development Survey (BUDS) to look into bioproduct development using biotechnologies. Results show that the development of bioproducts has become an intrinsic part of the activities of Canadian biotechnology firms.

    Release date: 2003-12-08

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27
Stats in brief (0)

Stats in brief (0) (0 results)

No content available at this time.

Articles and reports (2)

Articles and reports (2) ((2 results))

  • Articles and reports: 88F0006X2003013
    Description:

    This paper used data from the 2001 Biotechnology Use and Development Survey (BUDS) to look into bioproduct development using biotechnologies. Results show that the development of bioproducts has become an intrinsic part of the activities of Canadian biotechnology firms.

    Release date: 2003-12-08

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27
Journals and periodicals (0)

Journals and periodicals (0) (0 results)

No content available at this time.

Date modified: